menu search

JYNT / SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Joint Corp. - JYNT

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Joint Corp. - JYNT
New York, New York--(Newsfile Corp. - October 8, 2021) - Pomerantz LLP is investigating claims on behalf of investors of The Joint Corp. ("Joint" or the "Company") (NASDAQ: JYNT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.The investigation concerns whether Joint and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining... Read More
Posted: Oct 8 2021, 22:09
Author Name: Newsfile Corp
Views: 110628

JYNT News  

The Joint Corp.'s Q2 Was Not As Gloomy As It Seems

By Seeking Alpha
October 18, 2023

The Joint Corp.'s Q2 Was Not As Gloomy As It Seems

JYNT's Q2 2023 results show growth in revenue, total clinic count, and system-wide sales. The company is still expanding, opening new clinics and sell more_horizontal

The Joint (JYNT) Forays Into West Virginia Chiropractic Market

By Zacks Investment Research
September 27, 2023

The Joint (JYNT) Forays Into West Virginia Chiropractic Market

The Joint's (JYNT) new facility is positioned near the West Virginia University campus, at a high-traffic shopping center. more_horizontal

The Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View Down

By Zacks Investment Research
September 14, 2023

The Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View Down

The Joint (JYNT) expects to open 100-120 franchised clinics in 2023 compared with 121 opened last year. more_horizontal

The Joint Corp. (JYNT) Reports Q2 Loss, Misses Revenue Estimates

By Zacks Investment Research
September 13, 2023

The Joint Corp. (JYNT) Reports Q2 Loss, Misses Revenue Estimates

The Joint Corp. (JYNT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0 more_horizontal

The Joint Corp. to Participate in Upcoming Conferences

By GlobeNewsWire
September 6, 2023

The Joint Corp. to Participate in Upcoming Conferences

SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The J more_horizontal

The Joint Corp. (JYNT) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 10, 2023

The Joint Corp. (JYNT) Q2 2023 Earnings Call Transcript

The Joint Corp. (NASDAQ:JYNT ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations P more_horizontal

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

By Zacks Investment Research
August 8, 2023

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year. more_horizontal

The Joint Corp. to Host Conference Call on Thursday, August 10th to Discuss Second Quarter 2023 Results

By GlobeNewsWire
July 13, 2023

The Joint Corp. to Host Conference Call on Thursday, August 10th to Discuss Second Quarter 2023 Results

SCOTTSDALE, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Jo more_horizontal


Search within

Pages Search Results: